Greenwich Rx Recalled Compounded Glutathione Lots
The pharmacy issued a nationwide recall following reports of two patients requiring emergency medical care.
Updated on Oct. 1, 2026 in Economic Indicators
Greenwich Rx has initiated a voluntary nationwide recall of its compounded glutathione products due to the risk of elevated endotoxin levels. The recall follows two documented instances where patients required emergency care after receiving the injections.
Why it matters
Endotoxins can trigger severe inflammatory responses in patients, making the identification of affected medical supplies critical for safety. The recall ensures that potentially hazardous products are removed from circulation to prevent further adverse health events.
The recalled glutathione is formulated at a concentration of 200 mg/mL in 10mL vials. Greenwich Rx has provided a contact number of (866) 552-4916 for recall-related inquiries.
The players
Greenwich Rx
Greenwich Rx is a 503A compounding pharmacy located in Tomball, Texas, that specializes in creating customized medications.
The details
Greenwich Rx, a 503A compounding pharmacy based in Tomball, Texas, is notifying customers by mail to discontinue the use of the affected glutathione lots. The products were intended for subcutaneous injection, but the reported emergency cases involved intravenous administration.
Timeline
Distribution of the glutathione products began on June 26, 2026.
The distribution period concluded on September 21, 2026.
Greenwich Rx announced the voluntary recall on October 1, 2026.
Macro View
The recall highlights the ongoing regulatory oversight of 503A pharmacies regarding sterility and endotoxin testing protocols mandated by Section 503A of the Federal Food, Drug, and Cosmetic Act. This action marks a departure from standard safety compliance for pharmacies operating under this specific federal designation.
Customers who possess these vials should immediately cease administration and follow the disposal instructions provided by the pharmacy. Those experiencing adverse effects after use should consult a medical professional and report the incident through official channels.
The takeaway
Compounded medications bypass standard mass-production testing, which underscores the importance of verifying pharmacy quality standards. Patients should always confirm that specialized injections are sourced from pharmacies with verified safety protocols.
Further reading
For broader trends on market regulation and consumer safety, see Economic Indicators.
More information
To report adverse events related to this product, visit the FDA MedWatch Adverse Event Reporting program.
